Some experts doubt that the rule would have been capable of lowering drug prices.
Industry analysts expect the price for the single-treatment therapy to be anywhere from $1.5 million to $5 million.
The idea is that transparency would lead to more competition and lower costs. One drug company is already on board.
Pharmacy chain Walgreens reported a 3.8 percent drop in sales for the quarter. The company cited a weak cough, cold and flu season — and declining profits from generic and branded prescription drugs. Click the audio player above to hear…
The Food and Drug Administration has approved the first new kind of drug to treat depression since Prozac hit the scene in the late 1980s. Spravato is a nasal spray from Johnson & Johnson that’s a close cousin of ketamine, an…
Drug companies can get creative with doctor incentives, and that can be problematic.
More patients who are terminally ill will potentially have access to experimental drugs under a measure passed by the House last night. President Donald Trump is expected to sign the so-called “right-to-try” bill. Forty states have already passed similar legislation.…
Insurers are pushing back on manufacture coupons for expensive drugs in the hopes that it will pressure drug companies to lower prices.
"I set out to get safer products into the hands of everyone," Gregg Renfrew says.
The Uncertain Hour
Recently unsealed documents shed light on how the maker of OxyContin seems to have relied more on focus groups than on scientific studies to create an aggressive and misleading marketing campaign that helped fuel the national opioid epidemic.